期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

升高高密度脂蛋白的治疗进展 被引量：5

Treatment advances in increasing high density lipoprotein
下载PDF
导出
摘要 高密度脂蛋白具有重要的抗动脉粥样硬化作用。高密度脂蛋白通过促进胆固醇转运、改善血管内皮功能等多种作用机制发挥抗动脉粥样硬化作用。升高高密度脂蛋白可减少心血管事件的发生率。近年来许多新的升高高密度脂蛋白或载脂蛋白A-I的药物正在不断涌现。 High density lipoprotein possesses important function of anti-atherosclerosis through multiple mechanisms, such as enhancing cholesterol transport, promoting vasculay endothelial function, etc. Increasing high density lipoprotein may decrease the cardiovascular events. During recent years many new drugs are constantly emerging for the promotion of increasing the high density lipoprotein.
作者 黄震华
机构地区 上海交通大学医学院附属第九人民医院心血管病研究室
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第6期442-445,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 脂蛋白类 HDL 动脉粥样硬化 心血管疾病 心血管事件 lipoproteins, HDL atherosclerosis cardiovascular diseases cardiovascular events
分类号 R54 [医药卫生—心血管疾病] R972 [医药卫生—药品]
  • 相关文献

参考文献18

  • 1BARTER PJ, KASTELEIN JJ. Targeting cholesteryl eater transfer protein for the prevention and management of cardiovascular disease[J]. J Am Coll Cardiol, 2006, 47(3): 492-499.
  • 2MINEO C, SHAUL PW. HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action[J]. Trends Cardiovasc Med, 2003, 13(6): 226-231.
  • 3O'CONNELL BJ, GENEST J. High-density lipoproteins and endothelial function[J]. Circulation, 2001, 104(16): 1978-1983.
  • 4REILLY KB, SRINIVASAN S, HATLEY ME, et al. 12/15 lipoxygenase activity mediates inflammatory monocyte : endothelial interactions and atherosclerosis in vivo [J]. J Biol Chem, 2004, 279(10): 9440-9450.
  • 5FORRESTER JS, SHAH PK. Emerging strategies for increasing high-density lipoprotein[J]. Am J Cardiol, 2006, 98 (11 ) : 1542-1549.
  • 6ROBINS SJ, COLLINS D, WITTES JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial[J]. JAMA, 2001, 285(12) : 1585-1591.
  • 7BROWN BG, ZHAO XQ, CHAIT A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease[J]. N Engl J Med, 2001, 345 (22): 1583-1592.
  • 8de GROOTH GJ, KUIVENHOVEN JA, STALENHOEF AF, et al. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ dose-response study[J]. Circulation, 2002, 105 (18) : 2159- 2165.
  • 9OKAMOTO H, IWAMOTO Y, MAKI M, et al. Effect of JTT- 705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals[J]. Eur J Pharmacol, 2003, 466 (1 - 2): 147-154.
  • 10BROUSSEAU ME, SCHAEFER EJ, WOLFE ML, et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol[J]. N Engl J Med, 2004, 350(18): 1505-1515.

同被引文献44

引证文献5

二级引证文献21

中国新药与临床杂志
2008年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部